GB202113104D0 - Antagonist of pcsk9 - Google Patents

Antagonist of pcsk9

Info

Publication number
GB202113104D0
GB202113104D0 GBGB2113104.0A GB202113104A GB202113104D0 GB 202113104 D0 GB202113104 D0 GB 202113104D0 GB 202113104 A GB202113104 A GB 202113104A GB 202113104 D0 GB202113104 D0 GB 202113104D0
Authority
GB
United Kingdom
Prior art keywords
pcsk9
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2113104.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argonaute RNA Ltd
Original Assignee
Argonaute RNA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argonaute RNA Ltd filed Critical Argonaute RNA Ltd
Priority to GBGB2113104.0A priority Critical patent/GB202113104D0/en
Publication of GB202113104D0 publication Critical patent/GB202113104D0/en
Priority to EP22789482.1A priority patent/EP4402263A2/en
Priority to PCT/EP2022/075355 priority patent/WO2023041508A2/en
Priority to CA3229020A priority patent/CA3229020A1/en
Ceased legal-status Critical Current

Links

GBGB2113104.0A 2021-09-14 2021-09-14 Antagonist of pcsk9 Ceased GB202113104D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2113104.0A GB202113104D0 (en) 2021-09-14 2021-09-14 Antagonist of pcsk9
EP22789482.1A EP4402263A2 (en) 2021-09-14 2022-09-13 Treatment of cardiovascular disease
PCT/EP2022/075355 WO2023041508A2 (en) 2021-09-14 2022-09-13 Treatment of cardiovascular disease
CA3229020A CA3229020A1 (en) 2021-09-14 2022-09-13 Treatment of cardiovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2113104.0A GB202113104D0 (en) 2021-09-14 2021-09-14 Antagonist of pcsk9

Publications (1)

Publication Number Publication Date
GB202113104D0 true GB202113104D0 (en) 2021-10-27

Family

ID=78149336

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2113104.0A Ceased GB202113104D0 (en) 2021-09-14 2021-09-14 Antagonist of pcsk9

Country Status (1)

Country Link
GB (1) GB202113104D0 (en)

Similar Documents

Publication Publication Date Title
GB2594788B (en) Antagonist of PCSK9
IL277127A (en) Use of pcsk9 inhibitor for reducing cardiovascular risk
IL279363A (en) Pcsk9 antagonist compounds
ZA202205938B (en) Small molecule inhibitors of kras g12c mutant
IL281939A (en) Inhibitors of vap-1
IL284640A (en) Pcsk9 inhibitors and methods of use thereof
IL287751A (en) Kcnt1 inhibitors and methods of use
IL287768A (en) Kcnt1 inhibitors and methods of use
IL284661A (en) Pcsk9 inhibitors and methods of use thereof
EP3609882A4 (en) Heterocyclic inhibitors of pcsk9
IL281815A (en) Inhibitors of vap-1
IL292860A (en) Allosteric egfr inhibitors and methods of use thereof
SG11202109781QA (en) Uses of phosphodiesterase inhibitors
IL284570A (en) Quinoline compounds as inhibitors of tam and met kinases
GB201810746D0 (en) Use of sclerostin antagonist
GB201918463D0 (en) Plumbing fixture and methods of operation
GB202113104D0 (en) Antagonist of pcsk9
GB202020553D0 (en) Antagonist of pcsk9
GB202013998D0 (en) Antagonist of pcsk9
GB202003756D0 (en) Antagonist of PCSK9
GB2589398B (en) Compounds and methods of use
GB202215863D0 (en) Preparation of neosaxitoxin
ZA202105399B (en) Use of spiropidion
EP3968994C0 (en) Abhd12 inhibitors and methods of making and using same
KR102423280B9 (en) Sot-mram area-optimized design of sot-mram

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)